Free Trial
LON:N4P

N4 Pharma (N4P) Share Price, News & Analysis

N4 Pharma logo
GBX 0.75
+0.13 (+20.00%)
(As of 12:21 PM ET)

About N4 Pharma Stock (LON:N4P)

Key Stats

Today's Range
0.65
0.75
50-Day Range
0.45
0.65
52-Week Range
0.37
1.50
Volume
5.46 million shs
Average Volume
1.14 million shs
Market Capitalization
£2.96 million
P/E Ratio
N/A
Dividend Yield
3.12%
Price Target
N/A
Consensus Rating
N/A

Company Overview

N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

Receive N4P Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for N4 Pharma and its competitors with MarketBeat's FREE daily newsletter.

N4P Stock News Headlines

N4 Pharma (LON:N4P) Stock Price Up 18.2% - What's Next?
N4 Pharma PLC (N4P.AQ)
DeFi Coin on Verge of Breakout!
Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide…
N4 Pharma Plc Share Chat
See More Headlines

N4P Stock Analysis - Frequently Asked Questions

N4 Pharma's stock was trading at GBX 0.85 at the beginning of 2024. Since then, N4P shares have decreased by 11.8% and is now trading at GBX 0.75.
View the best growth stocks for 2024 here
.

N4 Pharma Plc (LON:N4P) posted its quarterly earnings data on Thursday, September, 17th. The company reported ($0.48) earnings per share for the quarter.

Shares of N4P stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that N4 Pharma investors own include 4D pharma (DDDD), Active Energy Group (AEG), B&M European Value Retail (BME), BP (BP), Coats Group (COA), EQTEC (EQT) and genedrive (GDR).

Company Calendar

Last Earnings
9/17/2020
Today
11/04/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Net Income
£-1,080,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£23,524.00
Cash Flow
GBX 0.28 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.47 million
Optionable
Not Optionable
Beta
-0.37
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (LON:N4P) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners